MODOMICS: a database of RNA modification pathways. 2021 update.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
07 01 2022
Historique:
accepted: 01 12 2021
revised: 16 10 2021
received: 29 09 2021
pubmed: 12 12 2021
medline: 23 2 2022
entrez: 11 12 2021
Statut: ppublish

Résumé

The MODOMICS database has been, since 2006, a manually curated and centralized resource, storing and distributing comprehensive information about modified ribonucleosides. Originally, it only contained data on the chemical structures of modified ribonucleosides, their biosynthetic pathways, the location of modified residues in RNA sequences, and RNA-modifying enzymes. Over the years, prompted by the accumulation of new knowledge and new types of data, it has been updated with new information and functionalities. In this new release, we have created a catalog of RNA modifications linked to human diseases, e.g., due to mutations in genes encoding modification enzymes. MODOMICS has been linked extensively to RCSB Protein Data Bank, and sequences of experimentally determined RNA structures with modified residues have been added. This expansion was accompanied by including nucleotide 5'-monophosphate residues. We redesigned the web interface and upgraded the database backend. In addition, a search engine for chemically similar modified residues has been included that can be queried by SMILES codes or by drawing chemical molecules. Finally, previously available datasets of modified residues, biosynthetic pathways, and RNA-modifying enzymes have been updated. Overall, we provide users with a new, enhanced, and restyled tool for research on RNA modification. MODOMICS is available at https://iimcb.genesilico.pl/modomics/.

Identifiants

pubmed: 34893873
pii: 6454677
doi: 10.1093/nar/gkab1083
pmc: PMC8728126
doi:

Substances chimiques

Enzymes 0
Ribonucleosides 0
RNA 63231-63-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

D231-D235

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Nucleic Acids Res. 2021 Jan 8;49(D1):D1388-D1395
pubmed: 33151290
Genes (Basel). 2021 Feb 26;12(3):
pubmed: 33652758
Nature. 2021 May;593(7860):597-601
pubmed: 33902106
RNA. 2021 Apr;27(4):367-389
pubmed: 33376192
FEBS J. 2021 Mar 3;:
pubmed: 33660392
Nucleic Acids Res. 2018 Jan 4;46(D1):D608-D617
pubmed: 29140435
Nucleic Acids Res. 2019 Jan 8;47(D1):D930-D940
pubmed: 30398643
Genome Biol. 2012 Oct 31;13(10):175
pubmed: 23113984
Nat Rev Cancer. 2020 Jun;20(6):303-322
pubmed: 32300195
J Cheminform. 2011 Oct 07;3:33
pubmed: 21982300
J Cheminform. 2013 May 21;5:24
pubmed: 23694746
RNA Biol. 2020 Nov;17(11):1560-1575
pubmed: 31994439
Mol Inform. 2013 Jun;32(5-6):481-504
pubmed: 27481667
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
Nat Rev Mol Cell Biol. 2017 Mar;18(3):202-210
pubmed: 28144031
Nucleic Acids Res. 2021 May 21;49(9):5382-5392
pubmed: 33956156
Nat Rev Drug Discov. 2018 Jun;17(6):435-453
pubmed: 29773918
Nucleic Acids Res. 2019 Mar 18;47(5):2143-2159
pubmed: 30698754
EMBO J. 2018 Sep 14;37(18):
pubmed: 30093495
Wiley Interdiscip Rev RNA. 2019 Jan;10(1):e1510
pubmed: 30311405
Exp Mol Med. 2020 Mar;52(3):400-408
pubmed: 32210357
Nucleic Acids Res. 2021 Jan 8;49(D1):D437-D451
pubmed: 33211854
Biochem J. 2021 Jul 16;478(13):2481-2497
pubmed: 34198328
Curr Opin Chem Biol. 2017 Dec;41:93-98
pubmed: 29125941
Bioinformatics. 2010 Dec 1;26(23):2988-9
pubmed: 20947523
RNA. 2018 Oct;24(10):1305-1313
pubmed: 29970597
Nucleic Acids Res. 2018 Jan 4;46(D1):D303-D307
pubmed: 29106616
NAR Cancer. 2021 Sep 16;3(3):zcab036
pubmed: 34541538
PLoS Genet. 2016 Jul 21;12(7):e1006139
pubmed: 27441695
Science. 2021 Jan 8;371(6525):145-153
pubmed: 33414215
Cell. 2017 Jun 15;169(7):1187-1200
pubmed: 28622506
Biomolecules. 2020 Sep 11;10(9):
pubmed: 32932892
Mol Cell. 2014 Oct 2;56(1):5-12
pubmed: 25280100

Auteurs

Pietro Boccaletto (P)

Laboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology in Warsaw, ul. Ks. Trojdena 4, PL-02-109 Warsaw, Poland.

Filip Stefaniak (F)

Laboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology in Warsaw, ul. Ks. Trojdena 4, PL-02-109 Warsaw, Poland.

Angana Ray (A)

Laboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology in Warsaw, ul. Ks. Trojdena 4, PL-02-109 Warsaw, Poland.

Andrea Cappannini (A)

Laboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology in Warsaw, ul. Ks. Trojdena 4, PL-02-109 Warsaw, Poland.

Sunandan Mukherjee (S)

Laboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology in Warsaw, ul. Ks. Trojdena 4, PL-02-109 Warsaw, Poland.

Elżbieta Purta (E)

Laboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology in Warsaw, ul. Ks. Trojdena 4, PL-02-109 Warsaw, Poland.

Małgorzata Kurkowska (M)

Laboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology in Warsaw, ul. Ks. Trojdena 4, PL-02-109 Warsaw, Poland.

Niloofar Shirvanizadeh (N)

Laboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology in Warsaw, ul. Ks. Trojdena 4, PL-02-109 Warsaw, Poland.

Eliana Destefanis (E)

Department of Cellular, Computational and Integrative Biology, University of Trento, Via Sommarive 9, 38123 Trento, Italy.

Paula Groza (P)

Department of Molecular Biology, Umeå University, SE-901 85 Umeå, Sweden.
Wallenberg Centre for Molecular Medicine, Umeå University, SE-901 85 Umeå, Sweden.

Gülben Avşar (G)

Department of Bioengineering, Gebze Technical University, 41400 Kocaeli, Turkey.

Antonia Romitelli (A)

Core Research Laboratory, ISPRO-Institute for Cancer Research, Prevention and Clinical Network, 50139 Firenze, Italy.
Department of Medical Biotechnologies, Università di Siena.

Pınar Pir (P)

Department of Bioengineering, Gebze Technical University, 41400 Kocaeli, Turkey.

Erik Dassi (E)

Department of Cellular, Computational and Integrative Biology, University of Trento, Via Sommarive 9, 38123 Trento, Italy.

Silvestro G Conticello (SG)

Core Research Laboratory, ISPRO-Institute for Cancer Research, Prevention and Clinical Network, 50139 Firenze, Italy.
Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.

Francesca Aguilo (F)

Department of Molecular Biology, Umeå University, SE-901 85 Umeå, Sweden.
Wallenberg Centre for Molecular Medicine, Umeå University, SE-901 85 Umeå, Sweden.

Janusz M Bujnicki (JM)

Laboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology in Warsaw, ul. Ks. Trojdena 4, PL-02-109 Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH